Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0106782 WOUND HEALING AND TISSUE ENGINEERING
The present invention is directed to wound healing scaffolds cografted with a population of stem cells, wherein the population of stem cells are ABCB5+ stem...
2016/0106781 HIGH TELOMERASE ACTIVITY BONE MARROW MESENCHYMAL STEM CELLS, METHODS OF PRODUCING THE SAME AND PHARMACEUTICALS...
Disclosed are isolated human bone marrow mesenchymal stem cells having high telomerase activity (tBMMSCs). Also disclosed are isolated human CD34.sup.+ bone...
2016/0106780 Methods and Compositions for Optimized Expansion and Implantation of Mesenchymal Stem Cells
Compositions and methods are provided for the optimized expansion and implantation of mesenchymal stem cells into a patient in need thereof. Autologous...
2016/0106779 NEUTROPHIL-DEPLETED WHOLE BLOOD AND PLATELET RICH PLASMA COMPOSITIONS
A particle/cell separation device is described which is particularly adapted for neutrophil depletion from a preparation of whole blood or platelet-rich...
2016/0106778 A MULTIPART FLUID SYSTEM AND A SYSTEM FOR CITRATE ANTICOAGUALATION IN AN EXTRACORPOREAL BLOOD CIRCUIT
The present invention concerns a multipart fluid system for dialysis therapy, wherein the multipart fluid system comprises an anticoagulation fluid and at...
2016/0106777 NOVEL COMPOSITION METHOD OF USING THE SAME FOR THE TREATMENT OF LYME DISEASE
A composition for treating Lyme disease caused by Borrelia Species, comprising a vitamin, a small fatty acid signaling molecule, an essential amino acid, a...
2016/0106776 FEED SUPPLEMENT AND ITS USE
The present invention relates to feed supplements comprising vitamins and canthaxanthin and the use of such supplements for improving performance and health in...
2016/0106775 COMPOSITIONS AND METHODS FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such...
2016/0106774 LIQUID PHARMACEUTICAL COMPOSITION CONTAINING PIROXICAM AND HYALURONIC ACID FOR THE TREATMENT OF OSTEOARTHRITIS
A pharmaceutical composition for the treatment of osteoarthritis comprising piroxicam or pharmaceutically acceptable salt thereof and hyaluronic acid or...
2016/0106773 TREATMENT FOR DISEASES RELYING ON DISCOVERY THAT THIOREDOXIN MEDIATES NITRIC OXIDE RELEASE IN CELLS
Patients having a disease associated with high level of thioredoxin system activity or a requirement for nitric oxide, e.g. large cell lymphoma or restenosis,...
2016/0106772 CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES
Materials, formulations, production methods, and methods for delivery of CFTR mRNA for induction of CFTR expression, including in the mammalian lung are...
2016/0106771 THERAPIES FOR CARDIOMYOPATHY
The present invention relates to therapies and therapeutic agents for use in the treatment of cardiomyopathies. In particular, the invention is concerned with,...
2016/0106770 EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER
This invention demonstrates the therapeutic efficacy of Yang-Gan-Wan (YGW) and its active components, especially in the formulation provided by Sheng-Pu...
2016/0106769 COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS
Compounds and methods for enhancing erythropoiesis. The compound contains a chemical structure of the formula (I) indicated below, in which R is a glucosyl...
2016/0106768 LYSOPHOSPHOLIPIDS AND LYSOPHOSPHOLIPID ANALOGUES AGAINST HONEYBEE BROOD DISEASES
The present invention refers to a compound selected from the group consisting of a lysophospholipid and a lysophospholipid analogue for use in the treatment or...
2016/0106767 USE OF PKC-IOTA INHIBITORS FOR THE TREATMENT OF BREAST CANCER
The subject invention pertains to uses of PKC-iota inhibitors for treatment of breast cancer. In one embodiment, the subject invention provides novel uses of...
2016/0106766 SOLID COMPOSITION FOR ORAL ADMINISTRATION CONTAINING IBANDRONIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT...
An improved solid pharmaceutical composition for oral administration comprising ibandronic acid or a pharmaceutically acceptable salt thereof, vitamin D and...
2016/0106765 Carbidopa and L-Dopa Prodrugs and Methods of Use
The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa...
2016/0106764 Doxycycline Formulations, and Methods of Treating Rosacea
The present invention is directed to a pharmaceutical composition in unit dose form for orally delivering doxycycline to a human, the pharmaceutical...
2016/0106763 ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in...
2016/0106762 VITAMIN D RECEPTOR/SMAD GENOMIC CIRCUIT GATES FIBROTIC RESPONSE
The present disclosure provides compositions that include a nanoparticle and a compound that increases the biological activity of the vitamin D receptor (VDR)...
2016/0106761 Ophthalmologic Irrigation Solutions and Method
Solutions for perioperative intraocular application by continuous irrigation during ophthalmologic procedures are provided. These solutions include multiple...
2016/0106760 Topically Active Steroids for Use In Interstitial Pulmonary Fibrosis
The present invention features methods of delivering corticosteroids or metabolites thereof for treating inflammatory conditions otherwise difficult to cure...
2016/0106759 Transdermal Delivery
Dosing regimen for transdermal delivery of hormones comprising a monthly treatment cycle with a fixed treatment interval and a variable rest interval.
2016/0106758 Transdermal Delivery
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
2016/0106757 OPHTHALMIC SOLUTIONS
An ophthalmic formulation which is an aqueous solution of a prostaglandin derivative, the prostaglandin derivative being ...
2016/0106756 BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCER
The present invention relates to the use of a benzodiazepine compound, and its use in the treatment of cancer, particularly small cell lung cancer.
2016/0106755 PHARMACEUTICAL COMPOSITIONS
Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect...
2016/0106754 USE OF CONDENSED BENZO[B]THIAZINE DERIVATIVES AS CYTOPROTECTANTS
The present invention relates to arylthiazine compounds, metabolites, N-oxides, amides, esters,pharmaceutically acceptable salts, hydrates and solvates thereof...
2016/0106753 Dihydro-Benzo-Oxazine and Dihydro-Pyrido-Oxazine Derivatives
The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates...
2016/0106752 Use of CB1 Antagonists and/or Inverse Agonists for the Preparation of Drugs that Increase Motor Neuron Excitability
Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in...
2016/0106751 SMALL MOLECULAR INHIBITORS OF RAD51 RECOMBINASE AND METHODS THEREOF
The invention includes compositions comprising a selective small-molecule inhibitor of RAD51 recombinase and a pharmaceutically acceptable carrier. The...
2016/0106750 COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and...
2016/0106749 FATTY LIVER DISEASE TREATMENT USING GLUCOCORTICOID AND MINERALOCORTICOID RECEPTOR ANTAGONISTS
The present invention provides treatment of fatty liver disease using a class of pyrimidinedione cyclohexyl compounds.
2016/0106748 PHARMACEUTICAL GASTRO-RETENTIVE SOLID ORAL DOSAGE FORM OF NILOTINIB
The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is...
2016/0106747 TREATING POSTOPERATIVE MECHANICAL STRESS WITH AN ECTOINE
A method of treatment of a patient suffering from postoperative inflammatory stress and pain caused by mechanical impact exerted on portions of the body of the...
2016/0106746 PHARMACEUTICAL FORMULATIONS FOR TREATING OCULAR CONDITIONS
Described herein are pharmaceutical formulations for treating ocular conditions.
2016/0106745 DRY EYE TREATMENTS
Described herein are methods and pharmaceutical formulations for treating dry eye disease.
2016/0106744 METHODS OF INCREASING TEAR PRODUCTION
Described herein are methods and pharmaceutical formulations for increasing tear production.
2016/0106743 TOPOISOMERASE II POISONS AND METHODS OF MAKING AND USING SAME
Disclosed herein are compositions of Formula I and an optional anticancer drug. Also disclosed herein are methods of treating or preventing cancer using the same.
2016/0106742 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
Described herein are methods for using compounds that activate pyruvate kinase.
2016/0106741 ORAL PHARMACEUTICAL COMPOSITION FOR INCREASING HYPOXIA TOLERANCE
The present invention relates to an oral pharmaceutical composition for increasing hypoxia tolerance, characterized in that the pharmaceutical composition...
2016/0106740 Treating Pain In Patients With Hepatic Impairment
An extended release composition for an analgesic active pharmaceutical ingredient which may be an opioid, preferably hydrocodone as the only active ingredient....
2016/0106739 Treating Pain In Patients With Hepatic Impairment
An extended release composition for an analgesic active pharmaceutical ingredient which may be an opioid, preferably hydrocodone as the only active ingredient....
2016/0106738 Treating Pain In Patients With Hepatic Impairment
An extended release composition for an analgesic active pharmaceutical ingredient which may be an opioid, preferably hydrocodone as the only active ingredient....
2016/0106737 Extended Release Abuse Deterrent Liquid Fill Dosage Form
The present disclosure relates to an oral, extended release, abuse deterrent dosage form containing a controlled release agent, a second agent and/or...
2016/0106736 DIHYDROETORPHINE FOR THE PROVISION OF PAIN RELIEF AND ANAESTHESIA
The present invention provides a method of providing pain relief in a human subject in need thereof comprising administering (R)-dihydroetorphine to said...
2016/0106735 Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response
Disclosed in certain embodiments is a method of treating or preventing an opioid induced adverse pharmacodynamic response comprising administering to a patient...
2016/0106734 Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions...
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine,...
2016/0106733 Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions...
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.